Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA | Zendy

Jasmine J. Han | Zendy; Christopher M. Tarney | Zendy; John W. Song | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA

Author(s) -

Jasmine J. Han,

Christopher M. Tarney,

John W. Song

Publication year - 2017

Publication title -

future oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.857

H-Index - 72

eISSN - 1744-8301

pISSN - 1479-6694

DOI - 10.2217/fon-2017-0147

Subject(s) - medicine , human papillomavirus , hpv infection , vaccination , sex organ , transmission (telecommunications) , gynecology , penile cancer , demography , genital warts , hpv vaccines , cervical cancer , cancer , immunology , sociology , biology , electrical engineering , genetics , engineering

Human papillomavirus (HPV) is the most common sexually transmitted infection that causes majority of anogenital and oropharyngeal cancers. Prophylactic HPV vaccine is available for the primary prevention of cancer and HPV transmission. Here, we are going to discuss the variation of HPV prevalence, HPV vaccination coverage and potential risk factors of men and women, retrieved from the cross-sectional study of the National Health Nutrition Examination Survey, a representative sample of noninstitutionalized, civilian residents in the USA. The overall penile HPV prevalence in men was 45.2% and the high risk oncogenic HPV prevalence defined by DNA testing was 25.1% that appeared to be widespread among all the age groups, which contrasts the vaginal HPV prevalence of 26.8% in women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research